NDLI: Global Control of Pneumococcal Infections by Pneumococcal Vaccines

Please wait, while we are loading the content...

Special Issue of the Contents of the Symposium Organized at 54th Annual Meeting for the Japanese Society of Tropical Medicine on October 4–5, 2013 in Nagasaki, Japan

Traditional Herbal Medicine for the Control of Tropical Diseases

Treatment of Parasitic Skin Diseases with Dimeticones A New Family of Compounds with a Purely Physical Mode of Action

MDA—Lymphatic Filariasis

Morbidity Control of Schistosomiasis by Mass Drug Administration: How Can We Do It Best and What Will It Take to Move on to Elimination?

Mass Drug Administration of Artemisinin-piperaquine on High Malaria Epidemic Area

About the J-GRID (Japan Initiative for Global Research Network on Infectious Diseases)

Population Based Cohort Study for Pediatric Infectious Diseases Research in Vietnam

Population-Based Interventions to Reduce the Public Health Burden Related with Hepatitis B Virus Infection in The Gambia, West Africa

Challenges to Clinical Research in a Rural African Hospital; a Personal Perspective from Tanzania

Analyses of Entry Mechanisms of Novel Emerging Viruses Using Pseudotype VSV System

Global Control of Pneumococcal Infections by Pneumococcal Vaccines

Requirements of New Vaccines against Novel Influenza Viruses

Global Efforts against HIV Epidemic and HIV Vaccine Development

Fukushima Nuclear Power Plant Accident and Comprehensive Health Risk Management—Global Radiocontamination and Information Disaster

Nodding Syndrome in Uganda: Field Observations, Challenges and Research Agenda

Year: 2014, Volume: 42, Issue: 2

Year: 2014, Volume: 42, Issue: 1

Year: 2013, Volume: 41

Year: 2012, Volume: 40

Year: 2011, Volume: 39

Global Control of Pneumococcal Infections by Pneumococcal Vaccines

Content Provider	PubMed Central
Author	Oishi, Kazunori Tamura, Kazuyo Akeda, Yukihiro
Copyright Year	2014
Abstract	Streptococcus pneumoniae is a major worldwide cause of morbidity and mortality. Pneumococcal carriage is considered to be an important source of horizontal spread of this pathogen within the community. Pneumococcal conjugate vaccine (PCV) is capable of inducing serotype-specific antibodies in sera of infants, and has been suggested to reduce nasopharyngeal carriage of vaccine-type pneumococci in children. PCV is generally immunogenic for pediatric patients with invasive pneumococcal disease, with an exception for the infecting serotypes. Based on evidences from the clinical trials of PCV, the health impact of childhood pneumococcal pneumonia appears to be high in developing countries where most of global childhood pneumonia deaths occur. PCV vaccination may prevent hundreds of deaths per 100,000 children vaccinated in developing countries, while PCV vaccination is expected to prevent less than 10 deaths per 100,000 children vaccinated in the developed countries. Therefore, the WHO has proposed a strategy to reduce the incidence of severe pneumonia by 75% in child less than 5 years of age compared to 2010 levels by 2025.
Related Links	http://dx.doi.org/10.2149/tmh.2014-s11
Page Count	1
Starting Page	83
File Format	PDF
ISSN	13488945
e-ISSN	13494147
Journal	Tropical Medicine and Health
Issue Number	2 Suppl
Volume Number	42
Language	English
Publisher	The Japanese Society of Tropical Medicine
Publisher Date	2014-01-01
Access Restriction	Open
Rights Holder	The Japanese Society of Tropical Medicine
Subject Keyword	Public Health, Environmental and Occupational Health Infectious Diseases Research in Higher Education
Content Type	Text
Resource Type	Article
Subject	Infectious Diseases Public Health, Environmental and Occupational Health

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Administration of pneumococcal vaccine in Hajj.

Pneumococcal disease and use of pneumococcal vaccines in Taiwan

Pediatric Invasive Pneumococcal Disease in the United States in the Era of Pneumococcal Conjugate Vaccines

The prevention of pneumococcal infections

Administration of pneumococcal vaccine in Hajj. Reply to Razavi SM and Salamati P.

Identifying UK travellers at increased risk of developing pneumococcal infection: a novel algorithm

Pneumococcal conjugate vaccines: New hope for infancy

The potential for pneumococcal vaccination in Hajj pilgrims: expert opinion.

South Asia symposium on pneumococcal disease and the promise of vaccines – Meeting report

Global Control of Pneumococcal Infections by Pneumococcal Vaccines

Similar Documents

Administration of pneumococcal vaccine in Hajj.

Pneumococcal disease and use of pneumococcal vaccines in Taiwan

Pediatric Invasive Pneumococcal Disease in the United States in the Era of Pneumococcal Conjugate Vaccines

The prevention of pneumococcal infections

Administration of pneumococcal vaccine in Hajj. Reply to Razavi SM and Salamati P.

Identifying UK travellers at increased risk of developing pneumococcal infection: a novel algorithm

Pneumococcal conjugate vaccines: New hope for infancy

The potential for pneumococcal vaccination in Hajj pilgrims: expert opinion.

South Asia symposium on pneumococcal disease and the promise of vaccines – Meeting report

Global Control of Pneumococcal Infections by Pneumococcal Vaccines